MetaCap

Prestige Consumer Healthcare (PBH) vs Zai Lab (ZLAB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Zai Lab (ZLAB) has outperformed Prestige Consumer Healthcare (PBH) over the past year, gaining 5.0% versus a loss of 16.5%. Over five years, PBH leads with a -12.0% price change compared with -72.7% for ZLAB. Zai Lab is the larger company by market cap ($2.63 billion vs $2.35 billion), about 1.1 times the size.

Prestige Consumer Healthcare converts more of its revenue into profit, with a net margin of 17.5% versus -38.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PBH-16.48%ZLAB+5.04%
+38%+4%-31%
Nov 21, 20251 yearNov 20, 2026
PBH-14.81%ZLAB-75.01%
+60%-15%-90%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PBH versus ZLAB key metrics
MetricPBHZLAB
Share price$49.63$21.03
Market cap$2.35B$2.63B
1-day change+0.06%-4.06%
YTD return-19.55%+19.22%
1-year return-16.48%+5.04%
5-year return-12.02%-72.67%
P/E ratio (TTM)15.32—
Forward P/E9.76—
EPS (TTM)$3.24$-1.80
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$1.09B$460.16M
Revenue growth (YoY)-4.31%+15.33%
Net income (latest FY)$190.30M$-175.54M
Gross margin54.71%58.60%
Operating margin28.42%-49.86%
Net margin17.48%-38.15%
52-week high$71.07$29.02
52-week low$41.77$15.96
Distance from 52-week high-30.17%-27.53%
Analyst consensusbuystrong_buy
Avg. price target upside+33.39%+62.67%
Average volume583.25K991.34K
Shares outstanding47.40M124.84M
Employees8901,784
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ZLAB has outperformed PBH by 21.5 percentage points over the past year.
  • Prestige Consumer Healthcare is more profitable, keeping 17.5 cents of every revenue dollar as net income versus -38.1 cents for Zai Lab.
  • Zai Lab grew revenue faster in its latest fiscal year (+15.33% vs -4.31%).

About Prestige Consumer Healthcare

PBH stock →

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Health Care · Biotechnology: Pharmaceutical Preparations · 890 employees

About Zai Lab

ZLAB stock →

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer.

Health Care · Biotechnology: Pharmaceutical Preparations · 1,784 employees

PBH vs ZLAB FAQ

Which is bigger, Prestige Consumer Healthcare or Zai Lab?

Zai Lab (ZLAB) is larger, with a market capitalization of $2.63B compared with $2.35B for Prestige Consumer Healthcare (PBH).

Which stock has performed better over the past year, PBH or ZLAB?

ZLAB returned +5.04% over the past 12 months, compared with -16.48% for PBH (price return, excluding dividends). Past performance does not predict future results.

Are Prestige Consumer Healthcare and Zai Lab in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons